DOI
stands for Digital Object Identifier
(
D
igital
O
bject
I
dentifier
)
,
and is the unique identifier for objects on the internet. It can be used to create persistent link and to cite articles.
Using DOI as a persistent link
To create a persistent link, add「http://dx.doi.org/」
「
http://dx.doi.org/
」
before a DOI.
For instance, if the DOI of an article is
10.5297/ser.1201.002
, you can link persistently to the article by entering the following link in your browser:
http://dx.doi.org/
10.5297/ser.1201.002
。
The DOI link will always direct you to the most updated article page no matter how the publisher changes the document's position, avoiding errors when engaging in important research.
Cite a document with DOI
When citing references, you should also cite the DOI if the article has one. If your citation guideline does not include DOIs, you may cite the DOI link.
DOIs allow accurate citations, improve academic contents connections, and allow users to gain better experience across different platforms. Currently, there are more than 70 million DOIs registered for academic contents. If you want to understand more about DOI, please visit airiti DOI Registration ( doi.airiti.com ) 。
建立及分析角膜新生血管相關脂肪性角膜病變之紐西蘭白兔動物模式
楊力權 , Masters Advisor:林中天 Co-advisor :陳偉勵
繁體中文
DOI:
10.6342/NTU.2011.00116
角膜新生血管 ; 高血脂症 ; 脂肪性角膜病變 ; 癌思停 ; corneal neovascularization ; hyperlipidemia ; lipid keratopathy ; bevacizumab


- 1. Ahmed A, Berati H, Nalan A, and Aylin S. Effect of bevacizumab on corneal neovascularization in experimental rabbit model. Clin Experiment Ophthalmol 37: 730-736, 2009.
連結: - 2. Al-Abdullah AA, and Al-Assiri A. Resolution of bilateral corneal neovascularization and lipid keratopathy after photodynamic therapy with verteporfin. Optometry 82: 212-214, 2011.
連結: - 3. Alfonso E, Arrellanes L, Boruchoff SA, Ormerod LD, and Albert DM. Idiopathic bilateral lipid keratopathy. Br J Ophthalmol 72: 338-343, 1988.
連結: - 4. Andreoli CM. Anti-vascular endothelial growth factor therapy for ocular neovascular disease. Curr Opin Ophthalmol 18: 502-508, 2007.
連結: - 5. Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MaA, and Giust MJ. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 113: 363-372, 2006.
連結: